Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Bortezomib
Related studies linked through entity extraction aliases.
Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bortezomib, Rituximab and Combination Chemotherapy in Treating Participants With Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Bevacizumab in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (AMBER)
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE2
Melphalan and Autologous Stem Cell Transplant Followed By Bortezomib and Dexamethasone in Treating Patients With Previously Untreated Systemic Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands
- Status
- COMPLETED
- Phase
- N/A
Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies.
- Status
- COMPLETED
- Phase
- N/A
Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE2
The Efficacy of Velcade on Bone Tissue During Myelomatosis (Bone Marrow Cancer)
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Rituximab in Treating Patients With Untreated Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
An Efficacy and Safety Study of Bortezomib Re-treatment in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Bortezomib in Patients With Advanced Malignancy
- Status
- COMPLETED
- Phase
- PHASE1